You are here:
Home
NICE Guidance
NICE Advice
Medtech innovation briefings
FebriDx for C-reactive protein and Myxovirus resistance protein A testing in primary care
Medtech innovation briefing
Reference number:
MIB114
Published:
31 July 2017
This advice has been updated and replaced by
NICE medtech innovation briefing 224
.
Back to top